Danaher (DHR) Q2 Earnings and Revenues Top Estimates

Core Viewpoint - Danaher (DHR) reported quarterly earnings of $1.8 per share, exceeding the Zacks Consensus Estimate of $1.64 per share, and showing a year-over-year decrease from $1.72 per share [1] Financial Performance - The company achieved revenues of $5.94 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.71% and increasing from $5.74 billion year-over-year [2] - Over the last four quarters, Danaher has exceeded consensus EPS estimates three times and topped revenue estimates four times [2] Stock Performance - Danaher shares have declined approximately 18.1% since the beginning of the year, contrasting with the S&P 500's gain of 7.2% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.80 on revenues of $6.02 billion, and for the current fiscal year, it is $7.70 on revenues of $24.52 billion [7] - The trend of estimate revisions for Danaher was unfavorable prior to the earnings release, which may impact future stock performance [6] Industry Context - The Medical Services industry, to which Danaher belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, suggesting potential challenges ahead [8]